Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438652 | 1.00 | HDAC6 (0.47) | HDAC6TSHRTP53PTPN1LMNA | |
| SCHEMBL17627664 | 1.00 | HDAC6 (0.47) | HDAC6TSHRTP53PTPN1LMNA | |
| SCHEMBL30105630 | 1.00 | HDAC6 (0.47) | HDAC6TSHRTP53PTPN1LMNA | |
| SCHEMBL17689577 | 0.83 | SMN1; SMN2 (0.48) | HDAC6PTPN1ALDH1A1ALOX15 | |
| SCHEMBL19139023 | 0.80 | HDAC6 (0.41) | HDAC6PTPN1ALDH1A1ALOX15 | |
| SCHEMBL21112084 | 0.75 | CYP2C19 (0.36) | TSHRTP53PTPN1LMNAALDH1A1 | |
| SCHEMBL31199127 | 0.74 | TSHR (0.46) | TSHRTP53LMNAALDH1A1MEN1 | |
| Isocyperol SCHEMBL29477342 | 0.73 | PTPN1 (0.44) | TSHRTP53PTPN1CA1CA2 | |
| Isocyperol SCHEMBL16663911 | 0.73 | PTPN1 (0.44) | TSHRTP53PTPN1CA1CA2 | |
| SCHEMBL17627637 | 0.73 | TRPA1 (0.54) | HDAC6TSHRLMNAALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 636 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283119-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC (US) | 2025-09-11 | — | — | US | claimed |
| US-20250073252-A1 | NON-PSYCHOACTIVE MULTI-CANNABINOID AND TERPENE-BASED THERAPEUTIC COMPOSITIONS AND METHODS OF THEIR ADMINISTRATION | PEBBLE GLOBAL HOLDINGS (US) | 2025-03-06 | — | — | US | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| WO-2024229503-A1 | AGARWOOD OIL NANOEMULSIONS, METHODS PERTAINING TO AND USES THEREOF | DEAURORA PTY LTD (AU) | 2024-11-14 | — | — | WO | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| WO-2024124354-A1 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PAIN OR OTHER DISORDERS | AIMA INC. (CA) | 2024-06-20 | — | — | WO | claimed |
| EP-4373507-A1 | METHODS AND COMPOSITIONS FOR MICROENCAPSULATED COMPOUNDS | Ojai Energetics PBC (US) | 2024-05-29 | — | — | EP | claimed |
| US-20240148759-A1 | Non-Psychoactive Multi-Cannabinoid And Terpene-Based Therapeutic Compositions And Methods Of Their Administration | PEBBLE GLOBAL HOLDINGS (US) | 2024-05-09 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-11931392-B2 | Use of Magnolia figo extract in the manufacture of compound for inhibiting growth of lung cancer cells | KUO, Chun-Sheng (TW) | 2024-03-19 | — | — | US | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| CN-102821771-B | Chinese toon supercritical extract for resisting diabetes and metabolism disease, preparation method and application | UNIV KAOHSIUNG MEDICAL | 2015-01-14 | — | — | CN | claimed |
| EP-2820958-A1 | COMPOSITION OF LEMON PEEL ESSENTIAL OIL AS A GROWTH PROMOTER IN THE POULTRY INDUSTRY | Universidad Peruana Cayetano Heredia (PE) | 2015-01-07 | — | — | EP | claimed |
| US-20140271940-A1 | BIOACTIVE CONCENTRATES AND USES THEREOF | SC LABORATORIES, INC. (US) | 2014-09-18 | — | — | US | claimed |
| CN-102821771-A | Chinese toon supercritical extract for resisting diabetes and metabolism disease, preparation method and application | UNIV KAOHSIUNG MEDICAL | 2012-12-12 | — | — | CN | claimed |
| CN-101142890-B | Cultivated agarwood | UNIV MINNESOTA | 2012-07-18 | — | — | CN | claimed |
| CN-102475702-A | A set of blood vessel dilating effective ingredients from Ligusticum chuanxiong volatile oil | INST CHINESE MATERIA MEDICA CHINA ACADEMY OF CMS | 2012-05-30 | — | — | CN | claimed |
| US-20110159127-A1 | EXTRACT OF TOONA SINENSIS FROM SUPERCRITICAL FLUID EXTRACTION FOR TREATING DIABETES AND METABOLIC DISEASES, THE PREPARATION METHOD AND THE USE THEREOF | METAL INDUSTRIES RESEARCH & DEVELOPMENT CENTRE (TW) | 2011-06-30 | — | — | US | claimed |
| US-6074634-A | MIXTURE CONTAINING PHENYLACETALDEHYDE, METHYL-2-METHOXY BENZOATE AND METHYL SALICYLATE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2000-06-13 | — | — | US | claimed |
| WO-2000019820-B1 | FEEDING ATTRACTANT AND STIMULANT FOR ADULT CONTROL OF NOCTUID AND/OR OTHER LEPIDOPTERAN SPECIES | US AGRICULTURE (US) | 2000-05-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140271940-A1 | BIOACTIVE CONCENTRATES AND USES THEREOF | CNR2, CNR1, CDIPT | HDAC6 3175/4885TSHR 4530/4885TP53 4871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.